Literature DB >> 15964153

Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of "super normal controls" in psychiatricgenetic research of complex behavioral disorders.

Thomas J H Chen1, Kenneth Blum, Daniel Mathews, Larry Fisher, Nancy Schnautz, Eric R Braverman, John Schoolfield, Bernard W Downs, David E Comings.   

Abstract

We hypothesize that pathological aggression, a complex behavioral disorder, in adolescents may in part involve polymorphisms of the dopaminergic system. While a number of neurotransmitter systems must be involved, due to polygenic inheritance, one major pathway should involve the dopaminergic system. Advances in our knowledge of the neurobiology of aggression and violence have given rise to rational pharmacological treatments for these behaviors. The main biological systems that are known to be involved are certain reward neurotransmitters including: serotonin, opioid peptides, gamma-aminobutyric acid, and the catecholamines (dopamine and norepinephrine). It is our notion that pathological aggressive behavior is in part similar mechanistically to other forms of impulsive behaviors such as pathological gambling. By analogy to drug dependence, it has been speculated that the underlying pathology in pathological gambling is a reduction in the sensitivity of the reward system. While studying pathological gamblers and controls during a guessing game using functional Magnetic Resonance Imaging, Reuter et al. observed a reduction of ventral striatal and ventromedial prefrontal activation in the pathological gamblers that were negatively correlated with gambling severity. Subsequently, linking hypo activation of these areas to disease severity. A positive correlation of both the dopamine D2 receptor gene (DRD2) and the dopamine transporter gene (DAT1) polymorphisms were observed with pathological violence in adolescents in a blinded clinical trial. Thus, this and other cited work preliminary suggest a role for both the DRD2 and DAT genes in pathological aggressive behavior. We further hypothesize that follow-up gene research in this area, albeit premature, resulting in confirmation of positive correlations with dopaminergic polymorphisms, and utilizing highly screened controls (eliminating any addictive, compulsive and impulsive behaviors in both proband and family) may have important ramifications in our young population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964153     DOI: 10.1016/j.mehy.2005.04.037

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  28 in total

Review 1.  Sex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphisms.

Authors:  Kenneth Blum; Tonia Werner; Stefanie Carnes; Patrick Carnes; Abdalla Bowirrat; John Giordano; Marlene Oscar-Berman; Mark Gold
Journal:  J Psychoactive Drugs       Date:  2012 Jan-Mar

2.  Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults.

Authors:  Guang Guo; Michael E Roettger; Jean C Shih
Journal:  Hum Genet       Date:  2006-10-31       Impact factor: 4.132

3.  Association of candidate genes with antisocial drug dependence in adolescents.

Authors:  Robin P Corley; Joanna S Zeiger; Thomas Crowley; Marissa A Ehringer; John K Hewitt; Christian J Hopfer; Jeffrey Lessem; Matthew B McQueen; Soo Hyun Rhee; Andrew Smolen; Michael C Stallings; Susan E Young; Kenneth Krauter
Journal:  Drug Alcohol Depend       Date:  2008-04-01       Impact factor: 4.492

4.  Dopamine Genetics and Function in Food and Substance Abuse.

Authors:  K Blum; M Oscar-Berman; D Barh; J Giordano; Ms Gold
Journal:  J Genet Syndr Gene Ther       Date:  2013-02-10

5.  THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCUITRY AND REDUCE ADDICTIVE BEHAVIORS.

Authors:  Kenneth Blum; B W Downs; Kristina Dushaj; Mona Li; Eric R Braverman; Lyle Fried; Roger Waite; Zsolt Demotrovics; Rajendra D Badgaiyan
Journal:  Precis Med (Bangalore)       Date:  2016-08-01

6.  Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

Authors:  Kenneth Blum; Edward J Modestino; Rajendra D Badgaiyan; David Baron; Panayotis K Thanos; Igor Elman; David Siwicki; Marcelo Febo; Mark S Gold
Journal:  EC Psychol Psychiatr       Date:  2018-07-30

Review 7.  Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?

Authors:  Mark S Gold; Kenneth Blum; Marlene Oscar-Berman; Eric R Braverman
Journal:  Postgrad Med       Date:  2014-01       Impact factor: 3.840

8.  GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM): LESSONS LEARNED FROM AMERICA.

Authors:  Kenneth Blum; Edward J Modestino; Marjorie C Gondré-Lewis; Jennifer Neary; David Siwicki; Mary Hauser; Debmalya Barh; Bruce Steinberg; Rajendra D Badgaiyan
Journal:  Precis Med (Bangalore)       Date:  2017-11-18

9.  The VNTR 2 repeat in MAOA and delinquent behavior in adolescence and young adulthood: associations and MAOA promoter activity.

Authors:  Guang Guo; Xiao-Ming Ou; Michael Roettger; Jean C Shih
Journal:  Eur J Hum Genet       Date:  2008-01-23       Impact factor: 4.246

10.  Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility.

Authors:  Kenneth Blum; Mary Hauser; James Fratantonio; Rajendra D Badgaiyan
Journal:  Addict Genet       Date:  2015-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.